title: Is it worthwhile to screen patients with type 2 diabetes mellitus for subclinical Cushing's syndrome?
abstract: Variable prevalence of subclinical Cushing's syndrome (SCS) has been reported in patients with type 2 diabetes mellitus (T2DM), making the need for screening in this population uncertain. It is unknown if this variability is solely due to study-related methodological differences or a reflection of true differences in ethnic predisposition. The objective of this study is to explore the prevalence of SCS in Asian Indian patients with T2DM. In this prospective single center study conducted in a tertiary care referral center, 993 T2DM outpatients without any discriminatory clinical features (easy bruising, facial plethora, proximal muscle weakness, and/or striae) of hypercortisolism underwent an overnight 1 mg dexamethasone suppression test (ODST). ODST serum cortisol ≥1.8 μg/dl was considered positive, and those with positive results were subjected to 48 h, 2 mg/day low dose DST (LDDST). A stepwise evaluation for endogenous hypercortisolism was planned for patients with LDDST serum cortisol ≥1.8 μg/dl. Patients with positive ODST and negative LDDST were followed up clinically and re-evaluated a year later for the development of clinically evident Cushing's syndrome (CS). In this largest single center study reported to date, we found 37 out of 993 (3.72%) patients had ODST serum cortisol ≥1.8 μg/dl. None of them had LDDST cortisol ≥1.8 μg/dl, nor did they develop clinically evident CS over a follow-up period of 1 year. Specificity of ODST for screening of CS was 96.3% in our cohort. None of the T2DM outpatients in our cohort had SCS, hence cautioning against routine biochemical screening for SCS in this cohort. We suggest screening be based on clinical suspicion only.
authors.affiliation: Department of EndocrinologySeth G S Medical College and KEM Hospital, Parel, Mumbai, Maharashtra 400012, India.
authors.forename: Sweta
authors.initials: S
authors.lastname: Budyal
authors.affiliation: Department of EndocrinologySeth G S Medical College and KEM Hospital, Parel, Mumbai, Maharashtra 400012, India.
authors.forename: Swati Sachin
authors.initials: SS
authors.lastname: Jadhav
authors.affiliation: Department of EndocrinologySeth G S Medical College and KEM Hospital, Parel, Mumbai, Maharashtra 400012, India.
authors.forename: Rajeev
authors.initials: R
authors.lastname: Kasaliwal
authors.affiliation: Department of EndocrinologySeth G S Medical College and KEM Hospital, Parel, Mumbai, Maharashtra 400012, India.
authors.forename: Hiren
authors.initials: H
authors.lastname: Patt
authors.affiliation: Department of EndocrinologySeth G S Medical College and KEM Hospital, Parel, Mumbai, Maharashtra 400012, India.
authors.forename: Shruti
authors.initials: S
authors.lastname: Khare
authors.affiliation: Department of EndocrinologySeth G S Medical College and KEM Hospital, Parel, Mumbai, Maharashtra 400012, India.
authors.forename: Vyankatesh
authors.initials: V
authors.lastname: Shivane
authors.affiliation: Department of EndocrinologySeth G S Medical College and KEM Hospital, Parel, Mumbai, Maharashtra 400012, India anuraglila@gmail.com.
authors.forename: Anurag R
authors.initials: AR
authors.lastname: Lila
authors.affiliation: Department of EndocrinologySeth G S Medical College and KEM Hospital, Parel, Mumbai, Maharashtra 400012, India.
authors.forename: Tushar
authors.initials: T
authors.lastname: Bandgar
authors.affiliation: Department of EndocrinologySeth G S Medical College and KEM Hospital, Parel, Mumbai, Maharashtra 400012, India.
authors.forename: Nalini S
authors.initials: NS
authors.lastname: Shah
keywords: overnight dexamethasone suppression test; screening; subclinical Cushing's syndrome; type 2 DM